Received Sep 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 1 | — | — |
unable to walk; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (unable to walk) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. Concurrent medical conditions included Multiple sclerosis. In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced GAIT INABILITY (unable to walk). At the time of the report, GAIT INABILITY (unable to walk) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. Patient experienced side effects following her first three to four Moderna vaccines. After her initial vaccination in 2021, she was unable to walk for 24 hours. Subsequent vaccinations resulted in similar side effects, but these resolved within 24 hours. There were no lab data/results available. It was unknown if the patient had any additional medical history, concomitant disease or risk factor. No treatment medication was reported. Reporter causality was not reported. This case was linked to MOD-2025-789439 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 16-Sep-2025: Live follow-up received: Reference id added.
Multiple sclerosis